PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Respiratory Medicine, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, People\'s Republic of China.\', \'Department of Respiratory and Infections Medicine, Beijing You An Hospital, Capital Medical University, Beijing, People\'s Republic of China.\', \'Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, The Clinical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People\'s Republic of China.\', \'Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/MD.0000000000027861
?:hasPublicationType
?:journal
  • Medicine
is ?:pmid of
?:pmid
?:pmid
  • 34964754
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.105
?:rankingScore_hIndex
  • 4
is ?:relation_isRelatedTo_publication of
?:title
  • Anticoagulation treatment for patients with coronavirus disease 2019 (COVID-19) and its clinical effectiveness in 2020: A meta-analysis study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all